Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|January 7, 2015
Recombinant interleukin-1 receptor antagonist attenuates the severity of chronic pancreatitis induced by TNBS in ratsChunfang Xu, Jiaqing Shen, Jing Zhang, et al.
BMC Cancer|October 26, 2022
Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4Shuai Hao, Shuyi Xu, Liangzhu Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2010
Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cellsJunfen Jiang, Mei Zhao, Aiying Zhang, et al.
Protein Expression and Purification|August 25, 2009
Purification of a bioactive recombinant human Reg IV expressed in Escherichia coliGuoyong Hu, Jiaqin Shen, Li Cheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 26, 2013
Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivoLan Qian, Di Xiang, Jing Zhang, et al.
Blood|April 5, 2012
Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicityHuili Lu, Shunying Zhu, Lan Qian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 2012
Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in miceJiaqing Shen, Jing Gao, Jing Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 5, 2010
Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis modelZhenqian Wu, Xiaodong Han, Shenyin Qin, et al.
Applied Biochemistry and Biotechnology|April 1, 2009
Expression, purification, and characterization of a novel soluble form of human Delta-like-1Mei Zhao, Mingyuan Wu, Lingchen Guo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 5, 2011
Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis modelZhenqian Wu, Xiaodong Han, Shenyin Qin, et al.
Pageof 4